Post-mortem neuropathologic examination of a 6-case series of CAR T-cell treated patients
Introduction: Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapy for the treatment of refractory hematopoietic malignancies.Adverse events are common, and neurotoxicity is one of the most important.However, the physiopathology is unknown and neuropathologic information is scarce.Materials and methods: Post-mortem examinatio